These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36889555)

  • 1. Factor Analysis of the Rome IV Criteria for Major Disorders of Gut-Brain Interaction (DGBI) Globally and Across Geographical, Sex, and Age Groups.
    Hreinsson JP; Törnblom H; Tack J; Drossman DA; Whitehead WE; Bangdiwala SI; Sperber AD; Palsson OS; Simrén M
    Gastroenterology; 2023 Jun; 164(7):1211-1222. PubMed ID: 36889555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor Analysis Defines Distinct Upper and Lower Gastrointestinal Symptom Groups Compatible With Rome IV Criteria in a Population-based Study.
    Clevers E; Whitehead WE; Palsson OS; Sperber AD; Törnblom H; Van Oudenhove L; Tack J; Simrén M
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1252-1259.e5. PubMed ID: 29510215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of disorders of gut-brain interaction in Western Europe and Asia based on the Rome foundation global epidemiology study.
    Hreinsson JP; Wong RKM; Tack J; Whorwell P; Benninga MA; Andresen V; Bonaz B; Choi SC; Corazziari ES; Santos J; Fukudo S; Kanazawa M; Fang X; Bangdiwala SI; Sperber AD; Palsson OS; Simrén M
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14566. PubMed ID: 36961016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology and impact of disorders of gut-brain interaction in Canada: Results from the Rome Foundation Global Epidemiologic Study.
    Rodrigues DM; Poitras P; Day AG; Sperber AD; Palsson O; Bangdiwala SI; Vanner SJ
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14585. PubMed ID: 36989173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of disorders of gut-brain interaction in the Japanese population in the Rome Foundation Global Epidemiological Study.
    Fukudo S; Nakaya K; Muratsubaki T; Nakaya N; Hozawa A; Bangdiwala SI; Palsson OS; Sperber AD; Kanazawa M
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14581. PubMed ID: 37093785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life.
    Sperber AD; Freud T; Aziz I; Palsson OS; Drossman DA; Dumitrascu DL; Fang X; Fukudo S; Ghoshal UC; Kellow J; Khatun R; Okeke E; Quigley EMM; Schmulson M; Simren M; Tack J; Whitehead WE; Whorwell P; Bangdiwala SI
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e945-e956. PubMed ID: 34052391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and description of disorders of gut-brain interaction in Spain according to the results of the Rome Foundation Global Epidemiology Study.
    Flores-Arriaga J; Aso MC; Izagirre A; Sperber AD; Palsson OS; Bangdiwala SI; Lanas Á; Bujanda L; Lobo B; Alonso-Cotoner C; Sánchez-Pla Á; Santos J
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14582. PubMed ID: 37010843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of disorders of Gut-Brain interaction in Israel: Results from the Rome Foundation global epidemiology study.
    Sperber AD; Freud T; Abu-Freha N; Shibli F; Brun R; Bangdiwala SI; Palsson OS; Dickman R
    Neurogastroenterol Motil; 2022 Aug; 34(8):e14323. PubMed ID: 35072332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Is Unspecified Functional Bowel Disorder? A Commonly Seen, Rarely Recognized, and Poorly Understood Diagnosis.
    Ballou S; Rangan V; Eidelberg A; Proctor S; McHenry N; Nee J; Iturrino J; Lembo A; Singh P
    Am J Gastroenterol; 2023 Aug; 118(8):1402-1409. PubMed ID: 37053553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample.
    Kwan AC; Bao T; Chakkaphak S; Chang FY; Ke M; Law NM; Leelakusolvong S; Luo JY; Manan C; Park HJ; Piyaniran W; Qureshi A; Long T; Xu GM; Xu L; Yuen H
    J Gastroenterol Hepatol; 2003 Jul; 18(7):796-802. PubMed ID: 12795751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology and psychological comorbidity of disorders of gut-brain interaction in Australia: Results from the Rome Foundation Global Epidemiology Study.
    Knowles SR; Apputhurai P; Palsson OS; Bangdiwala S; Sperber AD; Mikocka-Walus A
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14594. PubMed ID: 37052411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rome Foundation-Asian working team report: Asian functional gastrointestinal disorder symptom clusters.
    Siah KTH; Gong X; Yang XJ; Whitehead WE; Chen M; Hou X; Pratap N; Ghoshal UC; Syam AF; Abdullah M; Choi MG; Bak YT; Lu CL; Gonlachanvit S; Boon CS; Fang F; Cheong PK; Wu JCY; Gwee KA
    Gut; 2018 Jun; 67(6):1071-1077. PubMed ID: 28592440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
    Palsson OS; Whitehead W; Törnblom H; Sperber AD; Simren M
    Gastroenterology; 2020 Apr; 158(5):1262-1273.e3. PubMed ID: 31917991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disorders of Gut-brain Interaction on the US-Mexico Border: A Survey Using Rome IV Criteria.
    Bashashati M; Schmulson MJ; Sarosiek I; Robles A; Casner N; Espino K; Elhanafi SE; Zuckerman MJ
    J Clin Gastroenterol; 2024 Apr; 58(4):330-336. PubMed ID: 37267460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of competing diagnostic models of functional gastrointestinal disorders related to pain in children.
    Schurman JV; Karazsia BT; Friesen CA
    Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28656703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of functional gastrointestinal diseases in a cohort of Sri Lankan adolescents: comparison between Rome II and Rome III criteria.
    Devanarayana NM; Adhikari C; Pannala W; Rajindrajith S
    J Trop Pediatr; 2011 Feb; 57(1):34-9. PubMed ID: 20525779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the epidemiology of disorders of gut-brain interaction in four Latin American countries: Results of The Rome Foundation Global Epidemiology Study.
    Schmulson MJ; Puentes-Leal GA; Bustos-Fernández L; Francisconi C; Hani A; López-Colombo A; Palsson OS; Bangdiwala SI; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14569. PubMed ID: 36989176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.
    Black CJ; Houghton LA; Ford AC
    Neurogastroenterol Motil; 2022 Nov; 34(11):e14391. PubMed ID: 35531932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the pediatric Rome II criteria for functional gastrointestinal disorders using the questionnaire on pediatric gastrointestinal symptoms.
    Caplan A; Walker L; Rasquin A
    J Pediatr Gastroenterol Nutr; 2005 Sep; 41(3):305-16. PubMed ID: 16131985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.